We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Successful treatment with long-acting injectable aripiprazole monohydrate for two patients with dual diagnosis - substance use disorder and psychotic disorder.
- Authors
Erdogan, Ali; Kulaksizoglu, Burak; Bingol, Mert Sinan; Cinemre, Buket; Kuloglu, Mehmet Murat
- Abstract
In recent years, the rate of substance-induced psychotic disorder (SIPD) has been gradually increasing. Non-compliance with treatment and substance craving are serious problems in SIPD. Novel depot antipsychotic treatments, such as long-acting injectable aripiprazole monohydrate 400 mg (LAIAM) are reported to improve treatment compliance and functionality in psychotic disorders. However, the number of studies showing the efficacy of LAIAM treatment in patients with dual diagnosis is limited. In this paper, we present two cases. The first case was diagnosed with SIPD and the other was diagnosed with psychotic disorder with a past history of profound substance use disorder. The two cases showed both clinical and functional improvement at 1-year follow-up after the initiation of LAIAM treatment. These case reports suggest that LAIAM treatment might be an effective and safe treatment option in SIPD and reduce substance craving.
- Subjects
SUBSTANCE-induced psychoses; SUBSTANCE abuse; ARIPIPRAZOLE; DUAL diagnosis; INTRAMUSCULAR injections; TREATMENT effectiveness
- Publication
Dusunen Adam: Journal of Psychiatry & Neurological Sciences, 2021, Vol 34, Issue 1, p102
- ISSN
1018-8681
- Publication type
Article
- DOI
10.14744/DAJPNS.2021.00126